Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Frontiers in Medicine
|
January 4, 2021
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
Konstantin Kazankov, Chiara Rosso, Ramy Younes, et al.
BMC Gastroenterology
|
March 26, 2026
Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Claudio Sartini, Ronald Herrera, Faizan Mazhar, et al.
Journal of the American Society of Hypertension : JASH
|
January 26, 2018
Risk factors for arterial hypertension after liver transplantation
Cristina Di Stefano, Ester Vanni, Stefano Mirabella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 14, 2017
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study
Ramy Younes, Chiara Rosso, Salvatore Petta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Minerva Medica
|
May 14, 2019
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, et al.
Diagnostic Microbiology and Infectious Disease
|
February 4, 2020
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection
Gian Paolo Caviglia, Antonella Olivero, Alessia Ciancio, et al.
Journal of Hepatology
|
July 14, 2019
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
October 16, 2021
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
Beatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Clinical Medicine
|
January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Ramy Younes, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Frontiers in Medicine
|
January 4, 2021
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
Konstantin Kazankov, Chiara Rosso, Ramy Younes, et al.
BMC Gastroenterology
|
March 26, 2026
Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Claudio Sartini, Ronald Herrera, Faizan Mazhar, et al.
Journal of the American Society of Hypertension : JASH
|
January 26, 2018
Risk factors for arterial hypertension after liver transplantation
Cristina Di Stefano, Ester Vanni, Stefano Mirabella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 14, 2017
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study
Ramy Younes, Chiara Rosso, Salvatore Petta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Minerva Medica
|
May 14, 2019
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, et al.
Diagnostic Microbiology and Infectious Disease
|
February 4, 2020
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection
Gian Paolo Caviglia, Antonella Olivero, Alessia Ciancio, et al.
Journal of Hepatology
|
July 14, 2019
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
October 16, 2021
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
Beatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Clinical Medicine
|
January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Ramy Younes, et al.
Page
of 5